DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lopid (Gemfibrozil) - Diarrhoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Diarrhoea (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Lopid (Gemfibrozil) where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Lopid side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: female, weighing 113.0 kg (248.6 pounds)

Reactions: Contusion, Wrong Drug Administered, Oropharyngeal Pain, Headache, Pyrexia, Accidental Overdose, Abdominal Pain Upper, Abdominal Discomfort, Thinking Abnormal, Malaise, DRY Mouth, Dizziness, Drug Dispensing Error, Cough, Dyspnoea, Muscular Weakness, Dysgeusia, Dysstasia, Diarrhoea, Haemorrhagic Diathesis, Vision Blurred, Asthenia

Drug(s) suspected as cause:
Lopid

Other drugs received by patient: Norco; Gabapentin; Cymbalta



Possible Lopid side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient: female, weighing 113.0 kg (248.6 pounds)

Reactions: Contusion, Wrong Drug Administered, Oropharyngeal Pain, Headache, Pyrexia, Accidental Overdose, Abdominal Pain Upper, Abdominal Discomfort, Malaise, Thinking Abnormal, DRY Mouth, Dizziness, Drug Dispensing Error, Cough, Dyspnoea, Muscular Weakness, Dysgeusia, Dysstasia, Diarrhoea, Haemorrhagic Diathesis, Vision Blurred, Asthenia

Drug(s) suspected as cause:
Lopid

Other drugs received by patient: Cymbalta; Gabapentin; Norco



Possible Lopid side effects in 38 year old female

Reported by a consumer/non-health professional from United States on 2012-04-13

Patient: 38 year old female

Reactions: Diarrhoea, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Metformin HCL
    Dosage: (2500 mg,1 d),oral ; 1000 mg (1000 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-05-27
    End date: 2012-02-15

Metformin HCL
    Dosage: (2500 mg,1 d),oral ; 1000 mg (1000 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Diabetes Mellitus Inadequate Control
    Start date: 2011-05-27
    End date: 2012-02-15

Metformin HCL
    Dosage: (2500 mg,1 d),oral ; 1000 mg (1000 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-02-16

Metformin HCL
    Dosage: (2500 mg,1 d),oral ; 1000 mg (1000 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Diabetes Mellitus Inadequate Control
    Start date: 2012-02-16

Lopid
    Dosage: 1200 mg (600 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2012-02-15
    End date: 2012-02-16

Lopid
    Dosage: 1200 mg (600 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Type V Hyperlipidaemia
    Start date: 2012-02-15
    End date: 2012-02-16

Lopid
    Dosage: 1200 mg (600 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Diabetes Mellitus Inadequate Control
    Start date: 2012-02-15
    End date: 2012-02-16

Other drugs received by patient: Lantus; Cyclobenzaprine; Lisinopril; Glimepiride; Lovastatin



Possible Lopid side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05

Patient: female

Reactions: Diarrhoea, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Lopid
    Indication: Type V Hyperlipidaemia

Metformin HCL
    Dosage: 1000 mg, 1x/day
    Administration route: Oral
    Indication: Type V Hyperlipidaemia
    Start date: 2012-02-16

Metformin HCL
    Indication: Type 2 Diabetes Mellitus

Lopid
    Dosage: 600 mg, 2x/day
    Administration route: Oral
    Indication: Diabetes Mellitus Inadequate Control
    Start date: 2012-02-15
    End date: 2012-02-16

Lopid
    Indication: Type 2 Diabetes Mellitus

Metformin HCL
    Dosage: 2500 mg, daily
    Administration route: Oral
    Indication: Diabetes Mellitus Inadequate Control
    Start date: 2011-05-27
    End date: 2012-02-15

Other drugs received by patient: Lisinopril; Lantus; Lovastatin; Glimepiride; Lantus; Lisinopril; Glimepiride; Lantus; Cyclobenzaprine; Lantus



Possible Lopid side effects in 69 year old female

Reported by a consumer/non-health professional from United States on 2012-03-22

Patient: 69 year old female

Reactions: Diarrhoea, Drug Hypersensitivity

Drug(s) suspected as cause:
Lopid



Possible Lopid side effects in 38 year old female

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: 38 year old female

Reactions: Diarrhoea, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Lopid
    Dosage: 1200 mg (600 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-15
    End date: 2012-02-16

Metformin HCL
    Dosage: 2500 mg, 1 d, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-27
    End date: 2012-02-15

Metformin HCL
    Dosage: 2500 mg, 1 d, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-16

Other drugs received by patient: Lovastatin; Cyclobenzaprine; Glimepiride; Lisinopril; Lantus



Possible Lopid side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-08

Patient: female

Reactions: Diarrhoea, Diabetes Mellitus Inadequate Control

Drug(s) suspected as cause:
Metformin HCL
    Dosage: 1000 mg, 1x/day
    Administration route: Oral
    Start date: 2012-02-16

Lopid
    Dosage: 600 mg, 2x/day
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-02-16

Metformin HCL
    Dosage: 2500 mg, daily
    Administration route: Oral
    Start date: 2011-05-27
    End date: 2012-02-15

Other drugs received by patient: Lisinopril; Glimepiride; Lisinopril; Lantus; Lantus; Lantus; Glimepiride; Lantus; Cyclobenzaprine; Lovastatin



Possible Lopid side effects in female

Reported by a lawyer from United States on 2012-02-14

Patient: female, weighing 104.0 kg (228.8 pounds)

Reactions: Abdominal Pain, Contusion, Hyperkeratosis, Seborrhoeic Dermatitis, Diabetes Mellitus, Eczema, Tricuspid Valve Incompetence, Upper Extremity Mass, Neoplasm, Cardiac Disorder, Cardiomegaly, Malaise, Hepatotoxicity, Dermatitis, Upper Respiratory Tract Infection, Anal Pruritus, Melanocytic Naevus, Back Pain, Cushingoid, Functional Gastrointestinal Disorder, Drug Intolerance, Lumbar Radiculopathy, Rhinitis, Ill-Defined Disorder, Emotional Distress, Pancreatitis, Rosacea, Abscess, Painful Defaecation, Blood Triglycerides Increased, Stasis Dermatitis, Blood Cholesterol Increased, Oedema, Parotid Gland Enlargement, Shock Hypoglycaemic, Vomiting, Cataract, Mass, Carotid Bruit, Nerve Compression, Haematochezia, Atrophic Vulvovaginitis, Arthralgia, Physical Disability, Foot Deformity, Weight Decreased, Bile Duct Stone, Oesophageal Spasm, Cerebrovascular Disorder, Biliary Cirrhosis, Maculopathy, Carpal Tunnel Syndrome, Multiple Sclerosis, Muscle Spasms, Fluid Retention, Hepatic Cirrhosis, Dysphagia, Retinopathy, Acne, Abnormal Faeces, Faecal Incontinence, Venous Insufficiency, Eating Disorder, Fungal Infection, Rash Erythematous, Ear Pain, Cardiovascular Disorder, Spinal Column Stenosis, Nephropathy, Jaundice, Glaucoma, Pain, Blood Thyroid Stimulating Hormone Increased, Tonsillitis, Hepatitis, Constipation, Liver Disorder, Weight Increased, Hepatomegaly, Fatigue, Neuropathy Peripheral, Dizziness, Thrombocytopenia, Sinusitis, Gastrooesophageal Reflux Disease, Pharyngitis, Nausea, Rash, Jaundice Cholestatic, Onychomycosis, Macular Oedema, Anxiety, Mental Impairment, Renal Impairment, Diarrhoea

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Rezulin
    Dosage: daily
    Start date: 1998-04-28
    End date: 1998-07-15

Glucotrol XL
    Dosage: bid
    Administration route: Oral
    Indication: Diabetes Mellitus
    End date: 1998-09-24

Altace
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Start date: 1998-04-01
    End date: 1998-09-24

Glucophage
    Dosage: bid
    End date: 1998-09-24

Rezulin
    Dosage: daily
    Start date: 1997-12-02
    End date: 1998-01-12

Lopid
    Dosage: 600 mg, unk
    Indication: Blood Triglycerides Increased
    Start date: 1994-10-01
    End date: 1998-09-24

Zocor
    Dosage: q hs
    Administration route: Oral
    Indication: Ill-Defined Disorder
    Start date: 1993-10-01
    End date: 1998-09-24

Glucophage
    Dosage: maxiimum dose
    Start date: 1999-12-14

Rezulin
    Dosage: 2 qam
    Indication: Diabetes Mellitus
    Start date: 1997-03-01
    End date: 1997-12-01

Rezulin
    Dosage: daily
    Start date: 1998-01-13
    End date: 1998-04-27

Unspecified Antidepressants
    Indication: Back Pain
    Start date: 1997-01-01
    End date: 1997-01-01

Pregabalin
    Dosage: 600 mg, 1x/day
    Administration route: Oral
    Indication: Diabetic Neuropathy

Glucophage
    Dosage: 500 mg, 2x/day
    Indication: Diabetes Mellitus
    Start date: 1999-05-01
    End date: 1999-12-13

Glucophage
    Dosage: unk
    Start date: 1997-03-01
    End date: 1998-09-24

Glucophage
    Dosage: unk
    Start date: 1999-12-14

Other drugs received by patient: Precose; Humalog Regular Insulin; Diprolene Ascr; Catapres; Niacin; NPH Insulin; Nizoral Cream; Tricor; Zaroxolyn; Demadex; Aspirin; Potassium Chloride; Premarin; Lasix; Procardia; Amoxil; Timoptic-XE; LAC-Hydrin; Prednisone TAB; Metamucil-2



Possible Lopid side effects in female

Reported by a lawyer from United States on 2012-02-03

Patient: female, weighing 104.0 kg (228.8 pounds)

Reactions: Abdominal Pain, Contusion, Hyperkeratosis, Seborrhoeic Dermatitis, Diabetes Mellitus, Tricuspid Valve Incompetence, Eczema, Neoplasm, Upper Extremity Mass, Cardiomegaly, Cardiac Disorder, Malaise, Upper Respiratory Tract Infection, Hepatotoxicity, Dermatitis, Anal Pruritus, Melanocytic Naevus, Cushingoid, Back Pain, Functional Gastrointestinal Disorder, Drug Intolerance, Lumbar Radiculopathy, Rhinitis, Ill-Defined Disorder, Emotional Distress, Rosacea, Pancreatitis, Abscess, Painful Defaecation, Blood Triglycerides Increased, Stasis Dermatitis, Blood Cholesterol Increased, Oedema, Shock Hypoglycaemic, Parotid Gland Enlargement, Cataract, Vomiting, Mass, Carotid Bruit, Nerve Compression, Haematochezia, Atrophic Vulvovaginitis, Arthralgia, Physical Disability, Weight Decreased, Foot Deformity, Bile Duct Stone, Oesophageal Spasm, Cerebrovascular Disorder, Biliary Cirrhosis, Maculopathy, Carpal Tunnel Syndrome, Multiple Sclerosis, Fluid Retention, Hepatic Cirrhosis, Muscle Spasms, Dysphagia, Retinopathy, Acne, Abnormal Faeces, Faecal Incontinence, Venous Insufficiency, Eating Disorder, Fungal Infection, Rash Erythematous, Ear Pain, Cardiovascular Disorder, Nephropathy, Spinal Column Stenosis, Jaundice, Glaucoma, Pain, Tonsillitis, Blood Thyroid Stimulating Hormone Increased, Constipation, Hepatitis, Liver Disorder, Weight Increased, Neuropathy Peripheral, Fatigue, Hepatomegaly, Dizziness, Sinusitis, Gastrooesophageal Reflux Disease, Thrombocytopenia, Pharyngitis, Nausea, Rash, Onychomycosis, Jaundice Cholestatic, Macular Oedema, Anxiety, Mental Impairment, Renal Impairment, Diarrhoea

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Rezulin
    Dosage: daily
    Start date: 1998-01-13
    End date: 1998-04-27

Pregabalin
    Dosage: 600 mg, 1x/day
    Administration route: Oral
    Indication: Diabetic Neuropathy

Glucophage
    Dosage: 500 mg, 2x/day
    Indication: Diabetes Mellitus
    Start date: 1999-05-01
    End date: 1999-12-13

Glucophage
    Dosage: unk
    Start date: 1999-12-14

Glucotrol XL
    Dosage: bid
    Administration route: Oral
    Indication: Diabetes Mellitus
    End date: 1998-09-24

Unspecified Antidepressants
    Indication: Back Pain
    Start date: 1997-01-01
    End date: 1997-01-01

Rezulin
    Dosage: 2 qam
    Indication: Diabetes Mellitus
    Start date: 1997-03-01
    End date: 1997-12-01

Rezulin
    Dosage: daily
    Start date: 1997-12-02
    End date: 1998-01-12

Lopid
    Dosage: 600 mg, unk
    Indication: Blood Triglycerides Increased
    Start date: 1994-10-01
    End date: 1998-09-24

Rezulin
    Dosage: daily
    Start date: 1998-04-28
    End date: 1998-07-15

Glucophage
    Dosage: unk
    Start date: 1997-03-01
    End date: 1998-09-24

Altace
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Start date: 1998-04-01
    End date: 1998-09-24

Zocor
    Dosage: q hs
    Administration route: Oral
    Indication: Ill-Defined Disorder
    Start date: 1993-10-01
    End date: 1998-09-24

Glucophage
    Dosage: bid
    End date: 1998-09-24

Glucophage
    Dosage: maxiimum dose
    Start date: 1999-12-14

Other drugs received by patient: Lasix; Diprolene Ascr; Demadex; NPH Insulin; Premarin; Amoxil; Prednisone TAB; Tricor; Aspirin; Precose; Potassium Chloride; Timoptic-XE; Catapres; Niacin; Procardia; Metamucil-2; Nizoral Cream; Humalog Regular Insulin; Zaroxolyn; LAC-Hydrin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017